Cholangiocarcinoma: delayed CT contrast enhancement patterns.
about
Hepatobiliary MR imaging with gadolinium-based contrast agentsImaging of liver cancer.Liver masses: a clinical, radiologic, and pathologic perspective.Multimodality imaging of intrahepatic cholangiocarcinoma.Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatmentClonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosisImaging of malignancies of the biliary tract- an update.Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.Role of radiology in the treatment of malignant hilar biliary strictures 1: review of the literature.Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRIValue of two-phase dynamic multidetector computed tomography in differential diagnosis of post-inflammatory strictures from esophageal cancer.Correlation between dynamic CT findings and pathological prognostic factors of small lung adenocarcinoma.Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.Detection of small (≤ 2 cm) pancreatic adenocarcinoma and surrounding parenchyma: correlations between enhancement patterns at triphasic MDCT and histologic features.S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report.Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity.Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection.The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures.Necrotizing granulomatous inflammation of the liver.Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma.Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.Decreased intratumoral arteries reflect portal tract destruction and aggressive characteristics in intrahepatic cholangiocarcinoma.Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.Preoperative assessment of hilar cholangiocarcinoma using multidetector-row CT: correlation with histopathological findings.Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.Contrast-enhanced ultrasound appearances of enhancement patterns of intrahepatic cholangiocarcinoma: correlation with pathological findings
P2860
Q24631773-0A93EA4E-015C-40F5-8C27-C891BD502A8DQ24654739-2959E7B0-C266-4E43-920B-1BA77D15E885Q30403670-B83741CB-F560-4DA0-A69C-317B001D0AB3Q33621543-1AD502B6-B5C5-4F42-9C09-95D465BF236CQ33867307-4DC0A245-4304-4899-AA2B-B288D994460FQ33979981-F9B2DCC2-B800-4CD5-8675-0D5DF1E2FB77Q35093239-E617CE04-FD24-4D38-A731-0AC16952ECE8Q35674607-72153BCA-6EAD-401E-A125-CD133CC88FB4Q35694451-88053391-BDFA-4B0D-9BC9-B604F09B1F04Q35720896-C471620C-8D50-4B94-9CAB-DA92E70701FBQ35925516-64B678CE-F628-48D7-8B67-F99E05B8CA43Q36084847-DCC31D22-4CF1-4F48-B6E9-A0BA825E9A68Q36653288-77B54824-2297-4A30-9127-B2B2C99DECEFQ37487034-15154BC0-9431-4C93-B11E-EF7F7C5128C1Q37518982-A8F4D689-2D44-437A-B1A7-229C80D0575DQ37582068-5364C61F-C737-47AE-A397-A24706BC37A0Q37652891-59ED23C6-162F-46B9-8AEC-8658EFEF9B47Q38127390-9501F3BC-BA7C-441C-B5FC-B72C5D38B5CBQ38184373-12E29030-4204-4415-AE2B-5127DE636E59Q41232617-2568DDD2-E457-4099-A952-CB93DF25C52DQ46704438-ABA310C9-DCDE-40D0-99E6-432E75F797CAQ47603110-4F2EC71E-85AD-492A-8C6A-C0EB10030609Q48295712-7AE3C534-3015-425E-9C4F-C751DEEFAC7CQ51300458-D87504AB-1EB9-487C-8D22-1B5EAB551515Q51753375-A7AF9E76-0901-4C14-A206-C3D3AB3E5B7AQ53390053-E91BFE55-C93D-47F6-83A5-B896356D1C86Q53395926-B97C2C5E-EE3E-4CFE-AD34-56209523A3C4Q53511595-2367AB0D-ECDC-4E12-9B1D-BCCA69E30BA3Q56518214-6BEE15B5-EEC0-4172-8451-F235D7C4EEA3
P2860
Cholangiocarcinoma: delayed CT contrast enhancement patterns.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Cholangiocarcinoma: delayed CT contrast enhancement patterns.
@en
type
label
Cholangiocarcinoma: delayed CT contrast enhancement patterns.
@en
prefLabel
Cholangiocarcinoma: delayed CT contrast enhancement patterns.
@en
P2093
P1433
P1476
Cholangiocarcinoma: delayed CT contrast enhancement patterns.
@en
P2093
Federle MP
Lacomis JM
Nalesnik MA
Oliver JH 3rd
P304
P356
10.1148/RADIOLOGY.203.1.9122423
P407
P577
1997-04-01T00:00:00Z